
Opinion|Podcasts|February 5, 2025
Episode 2 Video: Identifying Patients with Intermediate Risk in NMIBC
Panelists explore challenges in identification of intermediate risk patients and emphasize importance of risk stratification to improve outcomes in regards to NMIBC.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA receives NDA submission for UGN-103 in recurrent LG-IR-NMIBC
2
Active surveillance use for low-risk prostate cancer reaches 93% in VA System
3
HoLEP learning curve and strategies for successful adoption, with Daniel S. Kellner, MD
4
Radium-223 fails to improve skeletal event-free survival in metastatic RCC
5

















